Company Description
Achillion Pharmaceuticals is looking for the Achilles heel of infectious disease. The firm is developing biopharmaceutical treatments for...
Key Achillion Financials
| Company Type | Public - NASDAQ (GM): ACHN Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $4.0 |
| Employees | -- |
More Achillion Financials (8 pages)
Competition
Competitive Landscape for Chemicals
Demand is driven by the health of the US economy because chemicals are used to make a wide variety of industrial and consumer products. The profitability of individual companies is closely tied to...
Read more about Achillion's competition across multiple industries
Top Achillion Competitors
Sponsored Links
The Business Directory
Achillion Executives
| Title | Name & Bio | Contact |
|---|---|---|
| President, CEO, and Director | Michael D. Kishbauch | Network | E-mail |
| VP and CFO | Mary Kay Fenton | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Achillion News
- Achillion Pharmaceuticals, Inc. (ACHN) Corporate Event Announcement Notice [Wall Street Horizon] (13 Aug 2008 20:41:00 EDT)
- Achillion Pharmaceuticals, Inc. (ACHN) Corporate Event Announcement Notice [Wall Street Horizon] (13 Aug 2008 20:36:00 EDT)
- Achillion Pharmaceuticals, Inc. (ACHN) Corporate Event Announcement Notice [Wall Street Horizon] (12 Aug 2008 20:36:00 EDT)
Sponsored Opportunity
